CDK Inhibition Results in Pharmacologic BRCAness Increasing Sensitivity to Olaparib in BRCA1-WT and Olaparib Resistant in Triple Negative Breast Cancer
CANCER LETTERS（2024）
Key words
BRCA1,TNBC,HRD,CDK9/12-Inhibitor,Pharmacologic-BRCAness
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined